Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Trial Identifier: D7632C00001
Sponsor: AstraZeneca
Collaborator:
Daiichi Sankyo
NCTID:: NCT06357533
Start Date: April 2024
Primary Completion Date: April 2028
Study Completion Date: May 2030
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AT Innsbruck, AT, 6020
AT Krems, AT, 3500
AT Linz, AT, 4020
AT Rankweil, AT, 6830
AT Wels, AT, 4600
AT Wien, AT, 1210
AT Wien, AT, 1140
AU Clayton, AU, 3168
AU Melbourne, AU, 3000
AU South Brisbane, AU, QL 4101
BE Anderlecht, BE, 1070
BE Hasselt, BE, 3500
BE La Louvière, BE, 7100
BR Barretos, BR, 14784-400
BR Curitiba, BR, 80730-150
BR Florianópolis, BR, 88034-000
BR Ipatinga, BR, 35162-189
BR Natal, BR, 59075-740
BR Porto Alegre, BR, 91350-200
BR Rio de Janeiro, BR, 22211-230
BR Santa Maria, BR, 97015-450
BR São Paulo, BR, 01221-020
BR Taubaté, BR, 12030-200
CA Chicoutimi, CA, G7H 5H6
CA, BC Vancouver, BC, CA, VSZ 4E6
CA, MB Winnipeg, MB, CA, R3E 0V9
CA, ON Newmarket, ON, CA, L3Y 2P9
CA, ON Oshawa, ON, CA, L1G 2B9
CA, ON Toronto, ON, CA, M4N 3M5
CA, Ontario London, Ontario, CA, N6A 4L6
CA, QC Lévis, QC, CA, G6V 0B8
CA, QC Montreal, QC, CA, H3T 1E2
CA, QC Montreal, QC, CA, H4J 1C5
CA, QC Rimouski, QC, CA, G5L 5T1
CA, QC Trois-Rivieres, QC, CA, G8Z 3R9
DE Gauting, DE, 82131
ES Alicante, ES, 03010
ES Barcelona, ES, 08003
ES Barcelona, ES, 08036
ES Jerez de la Frontera, ES, 11407
ES Reus,Tarragona, ES, 43204
ES Salamanca, ES, 37007
GB Cheltenham, GB, GL53 7AN
GB Inverness, GB, IV2 3UJ
GB London, GB, SE1 9RT
GB London, GB, SW10 9NH
GB London, GB, SW17 0QT
GB Truro, GB, TR1 3LJ
HU Budapest, HU, 1121
HU Győr, HU, 9024
HU Gyula, HU, 5700
HU Kecskemét, HU, 6000
HU Salgótarján, HU, 3100
HU Székesfehérvár, HU, 8000
HU Szekszárd, HU, 7100
HU Törökbálint, HU, 2045
IN Dwarka, IN, 110075
IN Jaipur, IN, 302004
IN Kolkata, IN, 700099
IN Marg Jaipur, IN, 302004
IN Nagpur, IN, 440001
IN Nashik, IN, 422011
IN New Delhi, IN, 11029
IN New Delhi, IN, 110085
IN Thiruvananthapuram, IN, 695011
IT Bergamo, IT, 24125
IT Genoa, IT, 16132
IT Milano, IT, 20162
IT Milano, IT, 20141
IT Monza, IT, 20052
IT Padova, IT, 35128
IT Pavia, IT, 27100
IT RAVENNA, IT, 48100
IT Roma, IT, 00128
IT Rozzano, IT, 20089
JP Hidaka-shi, JP, 350-1298
JP Kawasaki-shi, JP, 216-8511
JP Nagoya-shi, JP, 460-0001
JP Okayama, JP, 700-8558
JP Sagamihara-shi, JP, 252-0375
JP Sapporo-shi, JP, 003-0804
JP Takaoka-shi, JP, 933-8555
JP Takatsuki-shi, JP, 569-8686
JP Tokushima-shi, JP, 770-8503
JP Tokyo, JP, 104-0045
JP Utsunomiya-shi, JP, 320-0834
KR Changwon, KR, 51353
KR Incheon, KR, 21565
KR Seongnam-si, KR, 13496
KR Seoul, KR, 03080
KR Seoul, KR, 03722
KR Suwon, KR, 16247
KR Suwon-si, KR, 16499
PL Olsztyn, PL, 10-357
PL Poznań, PL, 60-569
PL Warszawa, PL, 01-138
TR Adapazarı, TR, 54100
TR Ankara, TR, 6200
TR Ankara, TR, 06560
TR Antalya, TR, 07070
TR Diyarbakir, TR, 21280
TR Istanbul, TR, 34030
TR Istanbul, TR, 34890
TW Kaohsiung, TW, 80756
TW New Taipei, TW, 220
TW Taichung, TW, 40447
TW Tainan, TW, 704
TW Taipei, TW, TAIWAN
TW Taipei, TW, 112
TW Taipei, TW, 10002
TW Taoyuan, TW, 333
US, AR Fayetteville, AR, US, 72703
US, AZ Tucson, AZ, US, 85719
US, CA Burbank, CA, US, 91505
US, FL Brandon, FL, US, 33511
US, FL Orlando, FL, US, 32827
US, GA Atlanta, GA, US, 30322
US, MA Boston, MA, US, 02114
US, MI Grand Rapids, MI, US, 49503
US, MS Hattiesburg, MS, US, 39401
US, NC Greenville, NC, US, 27834
US, NE Omaha, NE, US, 68130
US, Northern Plains San Juan, Northern Plains, US, 00935
US, NY Stony Brook, NY, US, 11794
US, OH Columbus, OH, US, 43210
US, SC Greenville, SC, US, 29607
US, TN Chattanooga, TN, US, 37404
US, TX Houston, TX, US, 77090
US, TX Kingwood, TX, US, 77339
US, VA Fort Belvoir, VA, US, 22060
US, VA Leesburg, VA, US, 20176
US, WA Tacoma, WA, US, 98405